Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells

Stem Cells Translational Medicine

Volumn 1, Issue 10, 2012, Pages 750-758

  Chase, Lucas G ^a   Yang, Sufang ^b,c   Zachar, Vladimir ^b   Yang, Zheng ^d   Lakshmipathy, Uma ^e   Bradford, Jolene ^f   Boucher, Shayne E ^g   Vemuri, Mohan C ^g  

^a Life Technologies   (United States)

^b AALBORG UNIVERSITY   (Denmark)

^c GUANGXI UNIVERSITY   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e Life Technologies   (United States)

^f MOLECULAR PROBES INC   (United States)

^g Life Technologies Inc   (United States)

Author keywords

Bone marrow stromal cells; Cellular therapy; Chondrogenesis; Culture; Differentiation; Marrow stromal stem cells; Microarray; Serum free medium

Indexed keywords

5' NUCLEOTIDASE; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE EXPRESSION; GENOMIC INSTABILITY; GOOD MANUFACTURING PRACTICE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STEM CELL; PHASE CONTRAST MICROSCOPY; PHYLOGENETIC TREE;

EID: 84875805101     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0072     Document Type: Article

References (34)

1. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-650.
2. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
3. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313-319.
4. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008;10:771-774.
5. Koç ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002;30:215-222.
6. Hare JM, Traverse JH, Henry TD et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-2286.
7. Cashman TJ, Gouon-Evans V, Costa KD. Mesenchymal stem cells for cardiac therapy: Practical challenges and potential mechanisms. Stem Cell Rev 2012 [Epub ahead of print].
8. Sotiropoulou PA, Perez SA, Salagianni M et al. Cell culture medium composition and translational adult bone marrow-derived stem cell research. STEM CELLS 2006;24:1409-1410.
9. Koppula PR, Chelluri LK, Polisetti N et al. Histocompatibility testing of cultivated human bone marrow stromal cells: A promising step towards pre-clinical screening for allogeneic stem cell therapy. Cell Immunol 2009;259:61-65.
10. English K, French A, Wood KJ. Mesenchymal stromal cells: Facilitators of successful transplantation? Cell Stem Cell 2010;7:431-442.
11. Santos FD, Andrade PZ, Abecasis MM et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: A microcarrier-based culture system under xeno-free conditions. Tissue Eng Part C Methods 2011;17:1201-1210.
12. Chase LG, Lakshmipathy U, Solchaga LA et al. A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 2010;1:8.
13. Pilgaard L, Lund P, Rasmussen JG et al. Comparative analysis of highly defined proteases for the isolation of adipose tissuederived stem cells. Regen Med 2008;3:705-715.
14. Pilgaard L, Lund P, Duroux M, et al. Effect of oxygen concentration, culture format and donor variability on in vitro chondrogenesis of human adipose tissue-derived stem cells. Regen Med 2009;4:539-548.
15. Pilgaard L, Lund P, Duroux M et al. Transcriptional signature of human adipose tissuederived stem cells (hASCs) preconditioned for chondrogenesis in hypoxic conditions. Exp Cell Res 2009;315:1937-1952.
16. Rasmussen JG, Frobert O, Pilgaard L et al. Prolonged hypoxic culture and trypsinization increase the pro-angiogenic potential of human adipose tissue-derived stem cells. Cytotherapy 2011;13:318-328.
17. Boucher SE. Simplified PCR assay for detecting early stages of multipotent mesenchymal stromal cell differentiation. Methods Mol Biol 2011;698:387-403.
18. Afizah H, Yang Z, Hui JH et al. A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng 2007;13:659-666.
19. Nikitina VA, Osipova EY, Katosova LD et al. Study of genetic stability of human bone marrow multipotent mesenchymal stromal cells. Bull Exp Biol Med 2011;150: 627-631.
20. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
21. Holzwarth C, Vaegler M, Gieseke F et al. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 2010;11:11.
22. Lindner U, Kramer J, Rohwedel J et al. Mesenchymal stem or stromal cells: Toward a better understanding of their biology? Transfus Med Hemother 2010;37:75-83.
23. Lund P, Pilgaard L, DurouxMet al. Effect of growth media and serum replacements on the proliferation and differentiation of adipose- derived stem cells. Cytotherapy 2009;11: 189-197.
24. Ng F, Boucher S, Koh S et al. PDGF, TGFbeta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008;112:295-307.
25. Lindroos B, Boucher S, Chase L et al. Serum- free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy 2009; 11:958-972.
26. Yang S, Pilgaard L, Chase LG et al. Defined xenogeneic-free and hypoxic environment provides superior conditions for longterm expansion of human adipose-derived stem cells. Tissue Eng Part C Methods 2012; 18:593-602.
27. Weijers EM, Van Den Broek LJ, Waaijman T et al. The influence of hypoxia and fibrinogen variants on the expansion and differentiation of adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A 2011; 17:2675-2685.
28. Fink T, Rasmussen JG, Lund P et al. Isolation and expansion of adipose-derived stem cells for tissue engineering. Front Biosci (Elite Ed) 2011;3:256-263.
29. Zachar V, Rasmussen JG, Fink T. Isolation and growth of adipose tissue-derived stem cells. Methods Mol Biol 2011;698:37-49.
30. Zachar V, Duroux M, Emmersen J et al. Hypoxia and adipose-derived stem cell-based tissue regeneration and engineering. Expert Opin Biol Ther 2011;11:775-786.
31. McIntosh K, Zvonic S, Garrett S et al. The immunogenicity of human adipose-derivedcells: Temporal changes in vitro. STEM CELLS 2006;24:1246-1253.
32. Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. STEM CELLS 2006;24:376-385.
33. Izadpanah R, Kaushal D, Kriedt C et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 2008;68:4229-4238.
34. Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003;75: 389-397.